CHLITINA Holding (麗豐-KY) announced consolidated revenue of NT$331 million for March, representing a 13.5% increase from the previous month and a 12.64% decline compared to the same period last year. Total revenue for the first quarter reached NT$798 million, down 20.09% year-on-year.
Despite ongoing adjustments in its core markets, CHLITINA Holding stated that it continues to steadily promote product upgrades and invest in R&D to lay the groundwork for future recovery. Its flagship brand, CHLITINA, has officially launched two newly certified products: the “Crystal Brightening Spot-Fading Series” and a new “Whitening Sunscreen.” These are expected to enter the market this year and inject new momentum into the company’s product portfolio, enhancing market share and differentiation in the high-efficacy skincare segment.
The Crystal Brightening Spot-Fading Series is a high-performance whitening line specifically designed for Asian skin. It features multiple spot-fading mechanisms and highly stable whitening ingredients, combined with gene-activating brightening technology and an intelligent oil-control system. The products target issues such as dark spots, uneven skin tone, and dullness, promoting a radiant glow from within. The series offers a one-stop, science-backed brightening regimen—from cleansing and essence infusion to repair and hydration. With a gentle yet effective formula, it caters to high-end consumers who value both performance and safety in skincare, providing a comprehensive whitening solution.
In addition, CHLITINA’s newly launched whitening sunscreen goes beyond traditional UV protection by offering dual functions: long-lasting UV defense and simultaneous skin brightening repair. It has passed multiple dermatological tolerance tests, ensuring a mild, non-irritating formula with all-day stable protection. This product has obtained dual certifications for whitening and sun protection and marks the first time CHLITINA has extended its functional skincare line into the domain of “daily protective whitening.” By expanding usage scenarios and increasing application frequency, it is poised to become a future flagship product.
Looking ahead to 2025, CHLITINA Holding remains confident in the positive trajectory of its business recovery. With China’s economy undergoing structural adjustments and consumer sentiment still cautious, competition among brands continues to intensify. In response, the company is adhering to a prudent management strategy centered on long-term value. It will continue to deepen its core operations while actively advancing AI-powered applications, biotech beauty solutions, and integration into the broader health and wellness industry, aiming to deliver competitive high-end skincare and personalized health management solutions.
Resource: 麗豐3月營收3.31億元 年減12.64%、月增13.5%
